These events that disrupt the BBB explain the finding that high levels of MMP‐9/ICAM‐1 are present before the appearance of new MRI‐based gadolinium‐enhancing lesions in MS patients.113, 114, 115. The gene discussed is ICAM1; the disease is myeloid sarcoma.